Unspecified chronic gastritis with bleeding
ICD-10 K29.51 is a billable code used to indicate a diagnosis of unspecified chronic gastritis with bleeding.
K29.51 refers to unspecified chronic gastritis with bleeding, a condition characterized by inflammation of the gastric mucosa that persists over time and is associated with gastrointestinal bleeding. The stomach, part of the alimentary tract, is affected, leading to symptoms such as abdominal pain, nausea, vomiting, and potentially hematemesis (vomiting blood). Chronic gastritis can result from various etiologies, including chronic infection with Helicobacter pylori, prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs), excessive alcohol consumption, or autoimmune disorders. Disease progression may lead to complications such as gastric ulcers or even gastric cancer if left untreated. Diagnosis typically involves endoscopic examination, biopsy, and laboratory tests to identify underlying causes. Clinicians must consider the patient's history, presenting symptoms, and risk factors when diagnosing and managing this condition, as timely intervention is crucial to prevent severe complications associated with gastrointestinal bleeding.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K29.51 encompasses chronic gastritis that is unspecified but includes the presence of gastrointestinal bleeding. It may be associated with various underlying conditions such as H. pylori infection, NSAID use, or autoimmune gastritis.
K29.51 should be used when chronic gastritis is diagnosed with documented bleeding, distinguishing it from codes for gastritis without bleeding or acute gastritis.
Documentation must include clinical findings, patient history indicating chronic gastritis, evidence of bleeding (e.g., lab results, endoscopy findings), and treatment plans that reflect the severity of the condition.
